19 October-30 November 2020
The 51st Union World Conference On Lung Health


EP11-TB: HIV and diabetes comorbidities
query_builder 10:00 - 11:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel E-poster session
mic English
EP11-TB: HIV and diabetes comorbidities
*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP11-197-22-Implementation of a mHealth strategy to increase linkage to and engagement in HIV care among people with TB and substance use in Irkutsk, SiberiaWe implemented a mobile health intervention designed to improve linkage and engagement in care for a tuberculosis/HIV co-infected, substance-using population in Irkutsk, Siberia. We evaluated the impact of this intervention, called MOCT (Russian for ‘bridge’), on various patient adherence measures as well as clinical outcomes over six months.
Jacqueline Hodges

EP11-198-22-Concomitant hepatitis B or C infection in patients with TB in the Netherlands: results of screening specific risk groupsThe Dutch Thoracic Society recommends screening specific risk groups of tuberculosis (TB) patients for hepatitis B and C. Data on this policy has been registered in the national TB register since 2019. Results show that this policy may contribute to elimination strategies set for these diseases in the Netherlands.
Jossy van den Boogaard

EP11-199-22-Impact of universal TB screening (TB-Surge) on HIV case finding in selected facilities. Lessons from the TB-Surge intervention in Akwa Ibom State, NigeriaUniversal tuberculosis (TB) screening - TB-Surge - was implemented to find missing TB cases in health facilities in AkwaIbom, a Nigerian state with high TB-HIV burden. Based on World Health Organization recommendation, HIV testing was offered to patients with presumptive TB. Universal TB screening can contribute significantly to early HIV diagnosis and commencement of antiretroviral theory (ART). 
Chukwuemeka Austin Ihesie

EP11-200-22-An assessment of free radical oxidation of small intestine enterocyte proteins in HIV-TB co-infectionThe article is devoted to the study of free radical processes in the mucous membrane of patients with HIV-TB co-infection. It is known that these processes are intensified under conditions of hypoxia, including cytotoxic origin caused by the inflammatory response in the lung tissue.
Liliia Todoriko

EP11-201-22-Monocyte and lymphocyte ratio as a predictor of TB among people living with HIV after antiretroviral therapy initiationIt is a challenge to diagnose tuberculosis (TB) among people living with HIV (PLWH) due to many of them having atypical presentation. We have demonstrated a simple tool that can help us predict TB incidence using monocytes to lymphocytes ratio (MLR) among HIV-infected people on antiretroviral therapy (ART).
Sivaporn Gatechompol

EP11-202-22-Comorbidities in Filipino people with active-TB disease: baseline data from the Starting Anti-TB Treatment (St-ATT) cohortFilipino data on the prevalence and patterns of comorbidities of malnutrition, diabetes, hypertension and anaemia are scarce. Malnutrition (BMI <17.0 kg/m2) was a common comorbidity (23.1%) followed by diabetes (22.7%), hypertension (14.8%), then anaemia (13.4%). Having >=1 comorbidities was more common in those with drug-resistant TB than those with drug-sensitive TB (61.8% vs 54.6%, p=0.05).
Shuichi Jack Suzuki

EP11-203-22-Prevalence of disseminated TB in HIV-infected persons admitted with sepsis at a tertiary hospital in western KenyaDiagnosis of disseminated tuberculosis (TB) in Persons Living with Human Immunodeficiency Virus (PLHIV) has been a challenge especially in resource-limited settings. The World Health Organization recommends lateral flow lipoarabinomannan antigen assay (LF-LAM) to aid in the diagnosis of active TB in PLHIV. However, its uptake in Kenya is still wanting.
Caroline Gituku

EP11-204-22-Is TB a major comorbidity in adolescent girls and young women living with HIV? A case in Turkana and Homa Bay Counties, KenyaWe documented tuberculosis (TB) testing, diagnosis, treatment initiation and outcomes of adolescent girls and young women (AGYW). AGYW received a comprehensive intervention including HIV testing, antiretroviral therapy (ART) initiation and treatment monitoring as well as increased access to GeneXpert MTB/RIF testing and alcohol acid fast bacilli, plus treatment of drug-sensitive TB with fixed dose combination.

Phelix Mboya

EP11-205-22-Is it necessary to screen for TB in diabetes patients and how to do it? An endocrinologist-based questionnaire survey in Hunan Province, ChinaIs it necessary to screen for tuberculosis (TB) in diabetes patients and how to do it? Let's see what the endocrinologists think and how they do it from an endocrinologist-based questionnaire survey in Hunan Province of China.
Chengli Bei

EP11-206-22-Prevalence of malarial and HIV co-infection among TB presumptive and asymptomatic children aged <5 years in Western KenyaWhile the intersection between HIV and tuberculosis (TB) is well documented, despite the high burden globally of TB and malaria among children, co-infection data is lacking. We studied the prevalence of malaria and HIV co-infection among Kenyan children aged <5 years with presumptive TB compared to asymptomatic controls.
Mark Fajans

EP11-207-22-Incidence of hypokalemia among drug-resistant TB patients receiving delamanid-containing regimen in LesothoA delamanid-containing regimen is commonly used in Lesotho even though it belongs to group C. This is mainly due to its safety profile as well as absence of drug-drug interaction with certain antiretroviral therapy (ART) and, as such, we investigate the incidence of hypokalemia in drug-resistant tuberculosis patients receiving a delamanid-containing regimen.
Lawrence Oyewusi

Processing. Please wait.